Literature DB >> 17625025

Low GABA concentrations in occipital cortex and anterior cingulate cortex in medication-free, recovered depressed patients.

Zubin Bhagwagar1, Marzena Wylezinska, Peter Jezzard, John Evans, Erie Boorman, Paul M Matthews, Philip J Cowen.   

Abstract

Studies using proton magnetic resonance spectroscopy (1H-MRS) indicate that unmedicated, acutely depressed patients have decreased levels of gamma-aminobutyric acid (GABA) in the occipital cortex. The aim of this study was to use 1H-MRS to determine if changes in occipital and frontal cortical GABA levels were present in patients with a history of depression who had recovered and were no longer taking medication. We used 1H-MRS to measure levels of GABA in both occipital cortex and anterior cingulate cortex/prefrontal cortex in medication-free, fully recovered subjects with a history of recurrent unipolar depression. Levels of GABA in both occipital and anterior cingulate cortex were significantly lower in recovered depressed subjects than healthy controls. Our data provide preliminary evidence that a history of recurrent depression is associated with decreased GABA levels in anterior cingulate cortex and occipital cortex. These changes could represent part of the neurobiological vulnerability to recurrent depressive episodes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17625025     DOI: 10.1017/S1461145707007924

Source DB:  PubMed          Journal:  Int J Neuropsychopharmacol        ISSN: 1461-1457            Impact factor:   5.176


  73 in total

Review 1.  GABA-based evaluation of neurologic conditions: MR spectroscopy.

Authors:  L M Levy; A J Degnan
Journal:  AJNR Am J Neuroradiol       Date:  2012-01-19       Impact factor: 3.825

Review 2.  In vivo magnetic resonance spectroscopy of GABA: a methodological review.

Authors:  Nicolaas A J Puts; Richard A E Edden
Journal:  Prog Nucl Magn Reson Spectrosc       Date:  2011-06-12       Impact factor: 9.795

3.  The GABAergic deficit hypothesis of major depressive disorder.

Authors:  B Luscher; Q Shen; N Sahir
Journal:  Mol Psychiatry       Date:  2010-11-16       Impact factor: 15.992

4.  Persistent β2*-nicotinic acetylcholinergic receptor dysfunction in major depressive disorder.

Authors:  Aybala Saricicek; Irina Esterlis; Kathleen H Maloney; Yann S Mineur; Barbara M Ruf; Anjana Muralidharan; Jason I Chen; Kelly P Cosgrove; Rebecca Kerestes; Subroto Ghose; Carol A Tamminga; Brian Pittman; Frederic Bois; Gilles Tamagnan; John Seibyl; Marina R Picciotto; Julie K Staley; Zubin Bhagwagar
Journal:  Am J Psychiatry       Date:  2012-08       Impact factor: 18.112

5.  Increased ventricular lactate in chronic fatigue syndrome. III. Relationships to cortical glutathione and clinical symptoms implicate oxidative stress in disorder pathophysiology.

Authors:  Dikoma C Shungu; Nora Weiduschat; James W Murrough; Xiangling Mao; Sarah Pillemer; Jonathan P Dyke; Marvin S Medow; Benjamin H Natelson; Julian M Stewart; Sanjay J Mathew
Journal:  NMR Biomed       Date:  2012-01-27       Impact factor: 4.044

6.  Reduced γ-aminobutyric acid in occipital and anterior cingulate cortices in primary insomnia: a link to major depressive disorder?

Authors:  David T Plante; J Eric Jensen; Laura Schoerning; John W Winkelman
Journal:  Neuropsychopharmacology       Date:  2012-02-08       Impact factor: 7.853

7.  Big GABA: Edited MR spectroscopy at 24 research sites.

Authors:  Mark Mikkelsen; Peter B Barker; Pallab K Bhattacharyya; Maiken K Brix; Pieter F Buur; Kim M Cecil; Kimberly L Chan; David Y-T Chen; Alexander R Craven; Koen Cuypers; Michael Dacko; Niall W Duncan; Ulrike Dydak; David A Edmondson; Gabriele Ende; Lars Ersland; Fei Gao; Ian Greenhouse; Ashley D Harris; Naying He; Stefanie Heba; Nigel Hoggard; Tun-Wei Hsu; Jacobus F A Jansen; Alayar Kangarlu; Thomas Lange; R Marc Lebel; Yan Li; Chien-Yuan E Lin; Jy-Kang Liou; Jiing-Feng Lirng; Feng Liu; Ruoyun Ma; Celine Maes; Marta Moreno-Ortega; Scott O Murray; Sean Noah; Ralph Noeske; Michael D Noseworthy; Georg Oeltzschner; James J Prisciandaro; Nicolaas A J Puts; Timothy P L Roberts; Markus Sack; Napapon Sailasuta; Muhammad G Saleh; Michael-Paul Schallmo; Nicholas Simard; Stephan P Swinnen; Martin Tegenthoff; Peter Truong; Guangbin Wang; Iain D Wilkinson; Hans-Jörg Wittsack; Hongmin Xu; Fuhua Yan; Chencheng Zhang; Vadim Zipunnikov; Helge J Zöllner; Richard A E Edden
Journal:  Neuroimage       Date:  2017-07-14       Impact factor: 6.556

8.  Dorsolateral prefrontal γ-aminobutyric acid in men predicts individual differences in rash impulsivity.

Authors:  Frederic Boy; C John Evans; Richard A E Edden; Andrew D Lawrence; Krish D Singh; Masud Husain; Petroc Sumner
Journal:  Biol Psychiatry       Date:  2011-07-14       Impact factor: 13.382

9.  Frontal lobe γ-aminobutyric acid levels during adolescence: associations with impulsivity and response inhibition.

Authors:  Marisa M Silveri; Jennifer T Sneider; David J Crowley; Michael J Covell; Deepa Acharya; Isabelle M Rosso; J Eric Jensen
Journal:  Biol Psychiatry       Date:  2013-03-14       Impact factor: 13.382

10.  Enhanced visual motion perception in major depressive disorder.

Authors:  Julie D Golomb; Jenika R B McDavitt; Barbara M Ruf; Jason I Chen; Aybala Saricicek; Kathleen H Maloney; Jian Hu; Marvin M Chun; Zubin Bhagwagar
Journal:  J Neurosci       Date:  2009-07-15       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.